Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Projected estimates of cancer in Canada in 2022.
Brenner DR, Poirier A, Woods RR, Ellison LF, Billette JM, Demers AA, Zhang SX, Yao C, Finley C, Fitzgerald N, Saint-Jacques N, Shack L, Turner D, Holmes E; Canadian Cancer Statistics Advisory Committee. Brenner DR, et al. Among authors: turner d. CMAJ. 2022 May 2;194(17):E601-E607. doi: 10.1503/cmaj.212097. CMAJ. 2022. PMID: 35500919 Free PMC article.
Projected estimates of cancer in Canada in 2020.
Brenner DR, Weir HK, Demers AA, Ellison LF, Louzado C, Shaw A, Turner D, Woods RR, Smith LM; Canadian Cancer Statistics Advisory Committee. Brenner DR, et al. Among authors: turner d. CMAJ. 2020 Mar 2;192(9):E199-E205. doi: 10.1503/cmaj.191292. Epub 2020 Mar 2. CMAJ. 2020. PMID: 32122974 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 35697369
Update on cancer incidence trends in Canada, 1984 to 2017.
Demers AA, Saint-Jacques N, Ellison L, Brenner D, Fitzgerald N, Aziz S, Turner D. Demers AA, et al. Among authors: turner d. Health Promot Chronic Dis Prev Can. 2022 Jul;42(7):301-305. doi: 10.24095/hpcdp.42.7.04. Health Promot Chronic Dis Prev Can. 2022. PMID: 35830219 Free PMC article.
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D, Shack L, Woods RR, Turner D, Leonfellner S, Ryan S, Saint-Jacques N, De P, McClure C, Ramanakumar AV, Stuart-Panko H, Engholm G, Walsh PM, Jackson C, Vernon S, Morgan E, Gavin A, Morrison DS, Huws DW, Porter G, Butler J, Bryant H, Currow DC, Hiom S, Parkin DM, Sasieni P, Lambert PC, Møller B, Soerjomataram I, Bray F. Arnold M, et al. Among authors: turner d. Lancet Oncol. 2019 Nov;20(11):1493-1505. doi: 10.1016/S1470-2045(19)30456-5. Epub 2019 Sep 11. Lancet Oncol. 2019. PMID: 31521509 Free PMC article.
International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Araghi M, Fidler-Benaoudia M, Arnold M, Rutherford M, Bardot A, Ferlay J, Bucher O, De P, Engholm G, Gavin A, Kozie S, Little A, Møller B, St Jacques N, Tervonen H, Walsh P, Woods R, O'Connell DL, Baldwin D, Elwood M, Siesling S, Bray F, Soerjomataram I; ICBP SURVMARK-2 Local Leads; ICBP SURVMARK-2 Academic Reference Group; ICBP Clinical Committee–Lung; ICBP SurvMark-2 Academic Reference GroupICBP SurvMark-2 academic reference group; ICBP Clinical Committee – LungICBP clinical Committee – lung. Araghi M, et al. Thorax. 2022 Apr;77(4):378-390. doi: 10.1136/thoraxjnl-2020-216555. Epub 2021 Jul 19. Thorax. 2022. PMID: 34282033 Free article.
3,734 results